Spironolactone Tablet, Film Coated
Product Images NDC 63629-5341

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-5341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Spironolactone 01)

Chemical structure of spironolactone shown as a molecular diagram with labeled functional groups, depicting its steroid backbone and associated chemical moieties.*

FDA Label Image

Figure 1 (Spironolactone 02)

A survival probability graph depicting two groups over time up to 48 months. The y-axis shows probability from 0.0 to 1.0, and the x-axis shows time in months. One solid line represents the Spironolactone group (n=822), and one dashed line represents the Placebo group (n=841). The chart includes a log-rank p-value less than 0.001, suggesting a statistically significant difference between the groups' survival probabilities over time.*

FDA Label Image

Figure 2 (Spironolactone 03)

A forest plot depicting hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups in a clinical study. The chart compares spironolactone versus placebo effectiveness across factors such as age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes presence, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. Each subgroup is shown with corresponding HR and CI markers, illustrating treatment benefit or risk.*

FDA Label Image

Label Image (Lbl636295341)

Label for Spironolactone 50 mg film-coated tablets by Bryant Ranch Prepack. The label includes a comparison to Aldactone 50 mg tablets by Frontida BioPharm, Inc. It indicates a package count of 30 tablets, prescription only, with storage instructions between 20°-25°C (68°-77°F). The label also includes an NDC code 63629-5341 and a barcode, with warnings to keep drugs out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.